Daniel M. Jorgensen

Chief Tech/Sci/R&D Officer at

Ocugen OpCo, Inc.

Health Technology

Consumer Services

Government

Profile

Daniel M.
Jorgensen currently works at Ocugen OpCo, Inc., as Chief Medical Officer from 2017.
Dr. Jorgensen also formerly worked at Critical Path Institute, as Chief Executive Officer from 2022 to 2024, PolyMedix, Inc., as Chief Medical Officer & SVP-Clinical Development, Centers for Disease Control & Prevention, as Epidemic Intelligence Service Officer, Innovation Pharmaceuticals, Inc., as Chief Medical Officer from 2015 to 2016, SANUWAVE Health, Inc., as Chief Medical Officer, Finch Research & Development LLC, as Chief Medical Officer from 2016 to 2017, and Ocugen, Inc., as Chief Medical Officer from 2017 to 2020.
Dr. Jorgensen received his graduate degree from the University of Washington, undergraduate degree and Masters Business Admin degree from Yale University, and doctorate degree from the University of Wisconsin.

Daniel M. Jorgensen active positions

Companies	Position	Start
Ocugen OpCo, Inc.	Chief Tech/Sci/R&D Officer	2017-03-31

All active positions of Daniel M. Jorgensen

Former positions of Daniel M. Jorgensen

Companies	Position	End
Critical Path Institute Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process	Chief Executive Officer	2024-01-08
OCUGEN, INC.	Chief Tech/Sci/R&D Officer	2020-07-14
Finch Research & Development LLC Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services	Chief Tech/Sci/R&D Officer	2017-03-31
INNOVATION PHARMACEUTICALS INC.	Chief Tech/Sci/R&D Officer	2016-02-29
Centers for Disease Control & Prevention Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center	Corporate Officer/Principal	-

See the detail of Daniel M. Jorgensen's experience

Training of Daniel M. Jorgensen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel M. Jorgensen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
PolyMedix, Inc. PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs	Health Technology
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale University Yale University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Centers for Disease Control & Prevention Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center	Government
Critical Path Institute Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process	Commercial Services
Innovation Pharmaceuticals, Inc. Innovation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases	Health Technology
SANUWAVE Health, Inc. SANUWAVE Health, Inc. Medical SpecialtiesHealth Technology Operates as a shockwave technology company using noninvasive, high energy, acoustic shockwaves for regenerative medicine and other applications	Health Technology
Finch Research & Development LLC Finch Research & Development LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services	Health Technology
Ocugen, Inc. Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products	Health Technology
Ocugen OpCo, Inc.